Quick Answer
GSK plc reported Total Assets of $61.12 billion for fiscal year 2025.
GSK plc Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $61.12B | +2.8% |
| 2024 | $59.46B | +0.8% |
| 2023 | $59.01B | -1.9% |
| 2022 | $60.15B | -24.0% |
| 2021 | $79.10B | -1.7% |
| 2020 | $80.43B | +0.9% |
| 2019 | $79.69B | +37.2% |
| 2018 | $58.07B | +3.0% |
| 2017 | $56.38B | — |
- GSK plc showed an increase of +2.8% in Total Assets compared to the prior fiscal year.
- Over the 2017–2025 period, GSK plc’s total assets has grown by 8.4% (from $56.38 billion to $61.12 billion).
- The most recent figure is from GSK plc’s fiscal year 2025 report (Form 20-F), filed with the SEC on March 6, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: